Resources

ASH 2019 – Top Data and Developments

The research objectives of this Syndicated Report:

  • Capture areas of greatest excitement regarding data presented or developments that took place during the American Society of Hematology (ASH) Annual Meeting, December 2019 in Orlando, FL.

Methodology: InCrowd MicroSurvey
Crowds: Hematologists and Hematology-Oncologists
Sample Size: n=75 physicians, each providing three separate mentions for a total of 225 unique data points
Fielding Period:
Two days immediately following conference close
Screening Criteria: Qualified respondents are US-based hems and hem/oncs who:

  • Attended the ASH Annual Meeting held between Dec 7–10, 2019 in Orlando, FL

Download the report now!

Please fill out the form below to access this content

Name(Required)
This field is for validation purposes and should be left unchanged.

Related Resources

Instant Insights – Weight Loss Drugs

Instant Insights – Weight Loss Drugs

Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...

read more
Post-ASCO Excitement Report

Post-ASCO Excitement Report

Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...

read more
2023 Q1 – NSCLC Essentials Readout

2023 Q1 – NSCLC Essentials Readout

Adoption of Newly-Approved 1L mNSCLC Regimens Driven by Promotional Activities Promotion plays a major role in the successful launch of a new pharmaceutical product. Companies must develop a marketing strategy that effectively communicates the benefits of the therapy...

read more